Kabiven Injection, Emulsion
Product Images NDC 63323-712

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Kabiven (NDC 63323-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Kab02 0000 01

An instructional diagram showing the components and features of a Kabiven intravenous emulsion injection bag, including overpouch notch, handle, hole for hanging, vertical seals, bends in vertical seals, horizontal seal, blind port, white additive port, blue infusion port, and oxygen absorber placement. The diagram helps identify each part of the bag for proper handling and use.*

FDA Label Image

Kab02 0000 02

An instructional diagram showing the steps to inspect and prepare a Kabiven 3-chambered intravenous emulsion bag prior to activation. The bag contains distinct chambers labeled for Dextrose, Amino Acids, and Lipids. Instructions include inspecting the bag for damage or discoloration, removing the overpouch by tearing from the notch, and discarding the overpouch and oxygen absorber.*

FDA Label Image

Kab02 0000 03

Instructional diagram for activating a Kabiven intravenous emulsion bag, showing hands manipulating the bag labeled with Dexrose, Amino Acids, and Lipids sections. Steps include placing the bag flat, rolling it to the ports, applying pressure to break vertical seals, mixing by inverting the bag, inspecting for white contents, and identifying the additive (white) and infusion (blue) ports.*

FDA Label Image

Kab02 0000 04

An instructional diagram showing the steps to make additions to an intravenous bag using an additive port. The images illustrate breaking off the white additive port cap, holding the additive port horizontally, inserting a needle through the septum to inject additives, and mixing thoroughly. The text emphasizes ensuring additive compatibility and aseptic technique, and notes the membrane's sterility and needle specifications for piercing the septum.*

FDA Label Image

Kab02 0000 05

Instructional diagrams showing steps to spike and hang a Kabiven intravenous infusion bag. The sequence illustrates breaking off the blue infusion port cap, inserting the spike by rotating the wrist, lifting and holding the bag with both hands, and hanging the bag by the hole below the handle. Text provides detailed procedural steps and a note on infusion port sterility and recommended infusion set specifications.*

FDA Label Image

Kab02 0000 06

Chemical structure diagram depicting the molecular formula of an active ingredient shown with hydroxyl groups (OH) and water of hydration (H2O). The structure appears to represent a sugar or carbohydrate molecule based on visible functional groups and ring formation.*

FDA Label Image

Kab02 0000 07

Chemical structure diagram of L-lysine, an amino acid component included in Kabiven. The structure shows a carbon backbone with an amino group and a carboxyl group.*

FDA Label Image

Kab02 0000 08

Chemical structure diagram of the active ingredient shown in the image. The structure features an amino acid with an amino group (NH2), a carboxyl group (COOH), and a side chain indicating it is likely an amino acid, consistent with the amino acids present in Kabiven injection emulsion.*

FDA Label Image

Kab02 0000 09

Chemical structure diagram of a compound showing a hydroxyl group (OH), amine group (NH2), and a carboxyl group (COOH). The specific molecule is not labeled in the image.*

FDA Label Image

Kab02 0000 10

Chemical structure diagram of a pyrimidine base, showing a six-membered ring with nitrogen atoms and an attached amino acid side chain, consistent with the structure of the active ingredient phenylalanine in Kabiven injection emulsion.*

FDA Label Image

Kab02 0000 11

Chemical structure of the active ingredient depicted as a molecular diagram attached to the product Kabiven, which contains multiple amino acids and nutrients. The diagram shows labeled atoms and bonds typical of a chemical structure representation.*

FDA Label Image

Kab02 0000 12

Chemical structure diagram of the active ingredient in the product Kabiven, showing a molecular structure with labeled functional groups including carbonyl, hydroxyl, and ethyl groups, consistent with an emulsion component typically found in intravenous injection formulations.*

FDA Label Image

Kab02 0000 13

Chemical structure diagram showing a general triglyceride molecule consisting of a glycerol backbone linked to three fatty acid chains (R1-C, R2-C, and R3-C) with ester bonds. This structural representation is consistent with components found in intravenous lipid emulsions like Kabiven.*

FDA Label Image

Kab02 0000 14

Chemical structure diagram showing a molecular structure with carbon (C), hydrogen (H), and oxygen (O) atoms, including double bonds and a carboxylic acid group, representing the chemical structure of an active ingredient component related to the drug product Kabiven.*

FDA Label Image

Kab02 0000 15

Chemical structure diagram showing the molecular formula of the active ingredient associated with the product, depicting a chain of carbon (C), hydrogen (H), oxygen (O) atoms, and their bonds in a complex organic molecule.*

FDA Label Image

Kab02 0000 16

Chemical structure diagram depicting a fatty acid molecule with a long hydrocarbon chain and a carboxyl group, representing the active ingredient's molecular structure in the product Kabiven, an intravenous injection emulsion by Fresenius Kabi USA.*

FDA Label Image

Kab02 0000 17

Chemical structure of the active ingredient in Kabiven, showing molecular bonds and atoms typically represented in a complex organic compound related to the mixture of nutrients in the intravenous emulsion.*

FDA Label Image

Kab02 0000 18

Chemical structure diagram depicting a complex molecule with multiple carbon (C) and hydrogen (H) atoms arranged primarily in chains and rings, featuring a carboxyl group (-COOH) at one end. The structure is typical of an organic compound, possibly representing one of the amino acids or fatty acid components in the product Kabiven.*

FDA Label Image

Kab02 0000 19

Chemical structure diagram depicting a molecule with a carboxyl group (COOH), amino group (NH2), and side chain with a benzene ring, representing the chemical structure of the active ingredient. The image shows atomic connections including carbon, hydrogen, nitrogen, and oxygen atoms in typical organic molecule layout.*

FDA Label Image

Kab02 0000 20

Chemical structure diagram showing two adjacent carbonyl groups with associated organic groups labeled as R1 and R2, depicting a general molecular structure often seen in organic chemistry.*

FDA Label Image

Kab02 0000 21

Chemical structure diagrams of phosphatidylcholine and phosphatidylethanolamine, two phospholipid molecules commonly found in lipid emulsions. The structures show detailed chemical groups including phosphate, choline, and ethanolamine components.*

FDA Label Image

Kab02 0000 22

Chemical structure diagram showing a molecular formula with carbon (C), hydrogen (H), and oxygen (O) atoms arranged in a specific layout, representing a component likely related to the active ingredients in the Kabiven intravenous emulsion injection.*

FDA Label Image

Kab02 0000 23

FDA Label Image

Kab02 0000 24

Label for Kabiven 1026 mL intravenous injection emulsion containing amino acids, electrolytes, dextrose, and lipid injectable emulsion. Manufactured by Fresenius Kabi USA, LLC. The label includes detailed activation instructions, NDC 63323-712-10 barcode, and port usage guidelines. Nutritional and electrolyte content per admixture is provided along with storage and handling recommendations.*

FDA Label Image

Kab02 0000 25

Label for Kabiven, an amino acids, electrolytes, dextrose, and lipid injectable emulsion for intravenous use. The package contains 4 containers of 1026 mL each. It is for central infusion and contains no sulfites. Manufactured by Fresenius Kabi USA, LLC in Uppsala, Sweden. Storage instructions and ordering information are provided, along with batch number and expiration dates.*

FDA Label Image

Kab02 0000 26

Kabiven 1540 mL injection emulsion, a combination of amino acids, electrolytes, dextrose, and lipid for intravenous use. The label shows the Fresenius Kabi logo, usage instructions including bag activation, and detailed nutritional content. It includes ports labeled for additives and infusion, volume markings, and a barcode. The product is intended for central infusion and contains no sulfites.*

FDA Label Image

Kab02 0000 27

Label for Kabiven injection, an amino acids, electrolytes, dextrose, and lipid injectable emulsion for intravenous use in a 4 x 1540 mL package. The label notes it is for central infusion and contains no added sulfites. It includes storage instructions, manufacturer Fresenius Kabi USA, LLC, and ordering information with contact details. The lot number and manufacture/use dates are also visible.*

FDA Label Image

Kab02 0000 28

Kabiven 2053 mL injection emulsion bag containing amino acids, electrolytes, dextrose, and lipid for intravenous use, manufactured by Fresenius Kabi. The label details activation instructions, nutritional information including total calories and electrolytes, and ports for additive and infusion. The bag is marked for central infusion and includes storage and usage warnings.*

FDA Label Image

Kab02 0000 29

Kabiven 4 x 2053 mL injection emulsion label showing it contains amino acids, electrolytes, dextrose, and lipid for intravenous use with specified concentrations. The label includes storage instructions (5°C to 25°C), manufacturer Fresenius Kabi USA, LLC, contact information, batch and date details, barcodes, and specifies it is for central infusion and prescription use only.*

FDA Label Image

Kab02 0000 30

Kabiven intravenous injection emulsion 2566 mL bag by Fresenius Kabi USA, LLC. Contains amino acids, electrolytes, dextrose, and lipid injectable emulsion with no sulfites added. The label includes instructions for activating the bag and ports for additive and infusion. Nutritional and electrolyte components per 100 mL are detailed on the label.*

FDA Label Image

Kab02 0000 31

Label for Kabiven amino acids, electrolytes, dextrose, and lipid injectable emulsion for intravenous use, central infusion. Contains 3 containers of 2566 mL each. Sterile single-dose container, no sulfites added. Manufactured by Fresenius Kabi USA, LLC in Uppsala, Sweden. Storage recommended at 5°C to 25°C (41°F to 77°F). Includes barcodes and batch information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.